NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

NCT06704009 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Age Related Macular Degeneration
Wet AMD

Interventions

DRUG: NT-101 Low Dose
DRUG: NT-101 High Dose

Sponsor

NexThera Co., Ltd.

Collaborators

[object Object]